IMA-PvPI: To ensure safety of medicines
IMA-PvPI: To ensure safety of medicines
Over 50% of all adverse drug reactions treated in hospitals and emergency care are preventable; IMA-PvPI center advocates strong action in this regard.
New Delhi, Feb 13, 2017: Adverse drug events (ADEs) result in significant injuries and deaths every year. Many ADE related injuries, mortalities and incurring hospital costs can be reduced if healthcare institutions strengthen their systems for preventing and detecting ADEs.
Under the IMA-PvPI initiative, Indian Medical Association (IMA) has become a nodal center for reporting of Adverse Drug Reactions (ADR) / Adverse Events (AE) under the Pharmacovigilance Programme of India (PvPI).
Padma Shri Awardee Dr K K Aggarwal, National President Indian Medical Association (IMA) and President Heart Care Foundation of India (HCFI) and Dr RN Tandon – Honorary Secretary General IMA in a joint statement stated that, “Medicines are developed over a period of several years. Efficacy and safety of a new drug are generally studied on a few thousand carefully selected and followed up trial subjects and patients according to strictly defined criteria. For this reason only very frequent adverse reactions and mainly those depending on the drug’s pharmacological properties can be observed during its clinical development. Once the product has been placed on the market, a much larger, and also often polymorbid population will be exposed, which may lead to a change in the drug’s known safety profile. Adverse drug reactions can then be observed more frequently, these new adverse reactions, should be reported without delay as a contribution to a potentially still incomplete safety profile. If such information is consistently forwarded to the competent authorities, unknown risks can be identified and tackled. ”
“Healthcare professionals and patients can report Adverse Drug Reactions due to Medicines, Vaccines, Medical-devices, blood products, Herbals products and others.
ADR/AE reporting can help all of us in our practice to know whether a particular effect is actually a side effect of a Drug or not and decide whether the production of that Drug needs to be stopped. IMA feels that reporting of such ADR/ AE under PvPI is the only means to know about the adverse effects of various drugs. In the interest of society, IMA has taken this step as a major project. Doctors and patients should be more proactive about reporting adverse drug events. ADR monitoring and reporting is still inadequate in India. Current adverse drug incident reporting system need to be improved, moreover, strengthening nursing medication and monitoring systems is also required”, added Dr. K.K Aggarwal.
Pharmacovigilance Programme of India started with the Vision to improve patient safety & welfare in Indian population by monitoring drug safety and thereby reducing the risk associated with the use of medicines. Healthcare professionals and patients can report Adverse Drug Reactions due to Medicines, Vaccines, Medical-devices, blood products, Herbals products and others through the IMA-PvPI ADRs reporting mobile no. 9717776514, 9:00 AM-5:30 PM, Monday–Friday.
-Ends-
About IMA: Indian Medical Association is the only representative, national voluntary organization of Doctors of Modern Scientific System of Medicine, which looks after the interest of doctors as well as the well being of the community at large. It has its Headquarter in Delhi and State / Terr. Branches in 30 States and Union Territories. It has over 2, 60,000 doctors as its members through more than 1765 active local branches spread across the country.
